Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cardiac Iron Overload”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Post-approval studies (Phase 4)Study completedNCT01736540
What this trial is testing

An Epidemiological Study to Assess Iron Overload Using MRI in Patients With Transfusional Siderosis (TIMES Study)

Who this might be right for
Thalassemia, Non-transfusional-dependent Thalassemia (NTDT), Myeloplastic Dysplasia (MDS), Other Anemia
Novartis Pharmaceuticals 243
Not applicableUnknownNCT02474420
What this trial is testing

Amlodipine as Adjuvant Treatment to Iron Chelation for Prevention of Cardiac Iron Overload in Thalassemia Patients

Who this might be right for
Beta-ThalassemiaIron Overload
Kevin H.M. Kuo, MD, MSc, FRCPC 60
Not applicableStudy completedNCT00512226
What this trial is testing

Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell Thalassemia

Who this might be right for
Sickle Cell AnemiaSickle Cell ThalassemiaIron Overload+1 more
HaEmek Medical Center, Israel 50
Testing effectiveness (Phase 2)Study completedNCT01254227
What this trial is testing

Efficacy and Safety of Deferasirox in Combination With Deferoxamine Followed by Deferasirox Monotherapy in Severe Cardiac Iron Overload

Who this might be right for
Cardiac Iron Overload
Novartis Pharmaceuticals 60
Not applicableStudy completedNCT00068159
What this trial is testing

Cardiac Function in Patients With Hereditary Hemochromatosis

Who this might be right for
Hereditary Hemochromatosis
National Heart, Lung, and Blood Institute (NHLBI) 70
Post-approval studies (Phase 4)Study completedNCT00673608
What this trial is testing

Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload

Who this might be right for
HemoglobinopathiesMyelodysplastic SyndromesOther Inherited or Acquired Anaemia+4 more
Novartis 118
Testing effectiveness (Phase 2)Ended earlyNCT01459718
What this trial is testing

Safety and Efficacy of Deferasirox in Combination With Desferoxamine in β-thalassaemia Patients With Severe Cardiac Iron Overload

Who this might be right for
Transfusion-dependent β-thalassemia PatientsCardiac Iron Overload
Novartis Pharmaceuticals 32
Not applicableApproved For MarketingNCT00293098
What this trial is testing

Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease

Who this might be right for
Iron Overload
Children's Hospital of Philadelphia
Testing effectiveness (Phase 2)Study completedNCT00600938
What this trial is testing

Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload

Who this might be right for
Transfusional Iron OverloadTransfusional Hemosiderosis
Novartis Pharmaceuticals 197
Not applicableStudy completedNCT00629291
What this trial is testing

MRI Evaluation of Iron Overload in the Heart, Liver and Pancreas in Patients Receiving Multiple Blood Transfusions.

Who this might be right for
Iron Overload
Sheba Medical Center 60
Not applicableStudy completedNCT02090699
What this trial is testing

MR Imaging of Diffuse Myocardial Fibrosis in Transfusion-Dependent Anemias

Who this might be right for
Thalassemia MajorChronic Blood Transfusion Related Iron Overload
University Health Network, Toronto 42
Post-approval studies (Phase 4)Study completedNCT00105495
What this trial is testing

Efficacy Study in Removing Excess Iron From the Heart

Who this might be right for
Thalassemia MajorHemosiderosis
ApoPharma 60
Not applicableStudy completedNCT00001203
What this trial is testing

Deferoxamine for the Treatment of Hemochromatosis

Who this might be right for
Diabetes MellitusHeart DiseaseHemochromatosis+1 more
National Heart, Lung, and Blood Institute (NHLBI) 151
Not applicableStudy completedNCT02671695
What this trial is testing

Effect of Spirulina Compared to Amlodipine on Cardiac Iron Overload in Children With Beta Thalassemia

Who this might be right for
Beta Thalassemia Major
Tanta University 40
Not applicableStudy completedNCT02527330
What this trial is testing

Evaluation of Myocardial Iron Deposition in Patients of Heart Failure Using T2* MR Imaging

Who this might be right for
Heart FailureIron OverloadCardiomyopathies
Chang Gung Memorial Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT07023666
What this trial is testing

Early Screening and Treatment of Heart Complication in Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Inova Health Care Services 100
Large-scale testing (Phase 3)Ended earlyNCT00981370
What this trial is testing

Clinical Importance of Treating Iron Overload in Sickle Cell Disease

Who this might be right for
Anemia, Sickle CellTransfusion Hemosiderosis
Children's Hospital Los Angeles 1
Not applicableStudy completedNCT02099214
What this trial is testing

Estimation of Myocardial Iron Overload by 3 Tesla MRI in HFE Hereditary Haemochromatosis

Who this might be right for
Myocardial Iron OverloadHFE-Associated Hereditary Hemochromatosis
Rennes University Hospital 66
Post-approval studies (Phase 4)Study completedNCT00800761
What this trial is testing

Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major

Who this might be right for
Iron OverloadCardiomyopathy
Ospedale Microcitemico
Testing effectiveness (Phase 2)Study completedNCT00447694
What this trial is testing

Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatment

Who this might be right for
Beta-thalassemiaIron Overload
Novartis 30
Next Page